Top Markets
#1 CyberDEX CyberDEX +678.13%
#2 GEKKO GEKKO +21.15%
#3 Harmony Harmony +20.18%
#4 龙虾 (Lobster) 龙虾 (Lobster) +16.62%
#5 DogBull DogBull +13.32%
#6 DexNet DexNet +12.63%
#7 Arweave Arweave +11.79%
#8 LayerZero LayerZero +11.43%
#9 Stargate Finance Stargate Finance +11.32%
#10 Backpack Backpack +10.34%
Coin of the day
CyberDEX CyberDEX
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Abbott Laboratories Abbott Laboratories

Abbott Laboratories

ABT
Kedudukan dalam Saham #118
Abbott Laboratories, along with its affiliated entities, is a global healthcare... Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.
Harga Saham
$97.46
Disegerakkan terakhir: 2026-10-02
Modal Pasaran
$168.63B
Perubahan (1 hari)
0.77%
Perubahan (1 tahun)
-27.59%
Negara
US
Perdagangan Abbott Laboratories (ABT)

Kategori

Healthcare
Nisbah P/E bagi Abbott Laboratories (ABT)
Nisbah P/E pada October 2026 TTM: 31.78
Menurut laporan kewangan dan harga saham terkini Abbott Laboratories, nisbah P/E semasa (TTM) ialah 31.78. Pada akhir 2024, syarikat mempunyai nisbah P/E sebanyak 14.62.
Sejarah nisbah P/E bagi Abbott Laboratories dari 2000 hingga 2026
Nisbah P/E pada akhir setiap tahun
Tahun Nisbah P/E Ubah
2026 (TTM) 31.78 -5.28%
2025 33.55 129.56%
2024 14.62 -56.18%
2023 33.35 20.14%
2022 27.76 -21.42%
2021 35.33 -18.19%
2020 43.19 3.69%
2019 41.65 -22.33%
2018 53.63 -74.29%
2017 208.61 416.25%
2016 40.41 170.24%
2015 14.95 -49.70%
2014 29.72 29.04%
2013 23.04 177.98%
2012 8.29 -7.25%
2011 8.93 16.57%
2010 7.66 10.25%
2009 6.95 -13.90%
2008 8.07 -29.75%
2007 11.49 -44.65%
2006 20.76 139.13%
2005 8.68 -19.34%
2004 10.76 -9.48%
2003 11.89 18.37%
2002 10.05 -59.93%
2001 25.07 107.16%
2000 12.10 0.00%
Nisbah P/E untuk syarikat serupa atau pesaing
Syarikat Nisbah P/E Perbezaan Nisbah P/E Negara
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 21.39 -32.70%
IE
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 28.32 -10.90%
US
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 17.60 -44.61%
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
 - -
DE
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 49.61 56.11%
US
Cara membaca nisbah P/E

Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.

Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.

Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.